Brant Nicks

Mr. Nicks serves as Senior Vice President, Clinical Solutions and Strategic Partnering for WCG, where he is focused on support for Hematology/Oncology solutions and efficiency. He is a seasoned executive with 28+ years of Clinical Research experience, responsible for growth and delivery of the hematology/oncology business through client-specific applications of WCGs vast array of services.

Prior roles include executive positions with PPD and PRA-- two of the five largest global CROs--as well as working for a mid-sized biotech on a drug program track that yielded regulatory approval for a long-standing blockbuster proteosome inhibitor. He has been responsible for large preferred provider relationships with top pharmaceutical companies in hematology/oncology development programs.

His experience spans the clinical development spectrum from first-in-human, early development, dose finding, cohort management studies, through to pivotal, late phase needs and FSP across a sizable spectrum of oncology indications. Throughout his career he has supported numerous drug approvals and label extensions for various agents and pathways. Brant is dedicated to driving excellence in delivery through implementation of best practices, continuous agile improvements and inspiring team engagement.